Demonstrates enhanced skin cancer diagnosis accuracy using multimodal deep learning framework, suggesting improved clinical applications.
The diagnosis of skin cancer remains a growing challenge because of its high variability as a result of the varying imaging conditions in clinical settings. This paper proposes a multimodal deep learning framework to address these challenges by combining the auxiliary clinical information with dermoscopic image features. This proposed architecture uses an attention-based feature encoder with a structured multimodal fusion approach to utilize the integrated feature representation across all channels. Evaluations of the proposed architecture were conducted across a range of benchmark datasets, including ISIC 2019, ISIC 2020, and HAM10000, using a unified experimental approach. This proposed model achieved accuracies of 90.5%, 88.7%, and 91.8% and AUCs of 95.8%, 94.6%, and 96.3%, respectively, on the selected datasets. For the baseline models, ResNet50 and EfficientNet-B4, our approach increased the AUC by 6.5% and the F1 score by 8.0%. Furthermore, across various datasets, the model achieved an AUC of 90.9%, proposing strong generalization. From the ablation analysis results, the attention and multimodal fusion mechanisms showed a 4.1% decrease in AUC when key components were removed, confirming their effectiveness. With 34.7 million parameters and an average of 19.3 Ms., the model has adequate intensity to deploy in a real clinical setting without affecting its performance. Additionally, the improvements to the model were statistically significant across all evaluation metrics (p = 0.01). The proposed multimodal framework demonstrates strong performance and robustness across multiple benchmark datasets.
No takes yet. Share an insight, caveat, or question.
Abdelbaki et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: